Browse > Article

Study on the modulation of immune system of CPS in atopic dermatitis induced animal models  

Lee, Youn-Jeong (Dept. of Pathology, College of Oriental Medicine, Daejeon University)
Gim, Seon-Bin (Traditional and Biomedical Research Center(TBRC), Daejeon University)
Choi, Hak-Joo (Traditional and Biomedical Research Center(TBRC), Daejeon University)
Lee, Ki-Moo (Doori Cosmetics)
Kim, Dong-Hee (Dept. of Pathology, College of Oriental Medicine, Daejeon University)
Publication Information
Journal of Haehwa Medicine / v.20, no.2, 2012 , pp. 1-16 More about this Journal
Abstract
In order to study the effect of CPS in the treatment of atopic dermatitis (AD), its role on various immune related cytokines were tested. Levels of liver and kidney function markers such as ALT, AST, BUN in NC/Nga mice were all normal indicating no toxicity in CPS treated group. Significant recovery from AD could be observed in CPS treated group through naked eye observation. Dermatitis index was significantly decreased after 11, 12, and 13 weeks of treatment. CD4+, CD8+, CD3+ /CD69+ immune cell ratio in DLN were decreased significantly by 37.2%, 49%, 20.8% in CPS treated group. CD4+ and CD11b+ /Gr-1+ immune cell ratio in dorsal skin were decreased significantly by 50.8% and 59.2% in CPS treated group. Expression of IL-4, IL-5, IL-6, IL-13 and TNF-${\alpha}$ in spleen were decreased by 78.8%, 97.8%, 64.7%, 73.6%, and 68.4%, respectively in CPS treated group. The results above strongly indicated the significant immune modulatory effect of CPS and thus clinical application of CPS on AD treatment.
Keywords
CPS(chunggipadoksan); atopic dermatitis; immune cell; cytokine;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Kevin DC, Atopic dermatitis: recenttrends in pathogenesis and therapy. Jinvest Dermatol, 102:128-37, 1994.   DOI
2 Epstein PR. Climate change and humanhealth. N Engl J Med, 353:1433-1436,2005.   DOI
3 Shea KM, Truckner RT, Weber RW,Peden DB. Climate change and allergicdisease. J Allergy Clin Immunol,122:443- 453, 2008.   DOI
4 Leung DYM, Pathogenesis of atopicdermatitis. J Allergy Clin Immunol,104:S99-108, 1999.   DOI
5 Leung DY, Atopy dermatitis: new insightand apportunities for for therapeuticintervention, J Allergy Clin Immunol,105:860-867, 2000.   DOI
6 Beellanti JA, Cytokine and allergicdisease; clinical aspect. Allergy Asthma Proc, 19(6):337-341, 1998.   DOI
7 Schreiber SL and Crabtree GR, Themechanism of action of cyclosporin Aand FK506. Immunol Today,13(4):136-42, 1992.   DOI
8 Robert Sidbury MD, Jon M. Hanifin MD,OLD, NEW, AND EMERGINGTHERAPIES FOR ATOPIC DERMATITIS.Dermatologic Clinics, 18(1):1-11, 2000.
9 이남열 : 아토피樣 피부염 NC/Nga 생쥐에서 滋陰除濕湯加減과 아토피 크림, 紫雲膏의 병용투여가 Th17 세포의 분화억제 및피부염에 미치는 영향, 대전대학교대학원,2009.
10 韓達秀 : 아토피樣 피부염 NC/Nga 생쥐에서 消風導赤湯加味와 아토피크림, 紫雲膏및 消風導赤湯加味의 병용투여가 피부염에미치는 영향, 대전대학교대학원, 2009.
11 高弘胤 : 아토피피부염에 대한 苦參加味方과 淸肌解毒散의 倂用 投與 效果, 대전대학교대학원, 2010.
12 조수익, 김진혜, 정보영, 안인수, 김혜원, 박천욱, 이철헌. 소아청소년 아토피피부염 환자의 삶의 질. 대한피부과학회지,49(5):415-421, 2011.
13 Holden CA and Parish WE, Atopicdermatitis. Blackwell Science, Oxford,1998.
14 김선빈, 최학주, 김동희. 아토피 피부염에 대한 황토가미방과 外治方 兼用에 관한 硏究, 대전대학교한의학연구소논문집, 17(2):51-68, 2008.
15 민영규, 최정화, 김종한, 박수연. 消風散加 減方과 外治方 병용이 NC/Nga 아토피 생 쥐에 미치는 영향, 한방안이비인후피부과학회지, 18(1):116-134, 2005.
16 황치환, 윤채성, 송승현, 원영호, 황충연. 葛根解肌湯加味方과 三黃洗劑加味方 병용이 NC/Nga 생쥐의 아토피 피부염에 미치 는 영향, 한방안이비인후피부과학회지, 21(2):1-18, 2008.
17 馮姍姍 : 外治方, 北京科學技術出版社, p.1, p.2, pp.40-44, 2010.
18 樊嵐嵐 : 名醫外治妙方, 浙江科學技術出版社, p.1, 2011.
19 박영립, 박준, 아토피 피부염의 병인, 대한피부연구학회지, 14(3):67-72, 2007.
20 허창훈, 아토피 피부염의 증상 및 치료, 한국산업간호협회지 13(3):42-46, 2006.
21 Wollenberg A, Kraft S, Oppel T, Bieber T, Atopic dermatitis: pathogenetic mechanism. Clin Exp Dermatol, 25:530-4, 2000.   DOI
22 Agnello D, Lankford CS, Bream J, Morinobu A, Gadina M, O'shea JJ and Frucht DM, Cytokines and transcription factors that regulate T helper cell differentiation: new players and new insights. J Clin Immunol, 23:147-61, 2003.   DOI
23 Blaser Kurt, Ring Johannes and Capron, T Cell Regulation in Allergy, Asthma and Atopic Skin Diseases. S Karger Pub, pp.121-137, 2008.
24 Romagnani S: immunologic influences on allergy and the Th1/Th2 balance. J Allergy Clin Immunol, 113;395-400, 2004.   DOI
25 陳實功 : 外科正宗, 北京, 人民衛生出版社, p.269, 1983.
26 全宰弘 : 자운고가 자외선에 의한 피부손상 및 광노화에 미치는 영향, 동국대학교대학원, 2007.
27 Leung DY, Hirsch RL, Schneider L, Moody C, Takaoka R, Li SH, Meyerson LA, Mariam SG, Goldstein G and Hanifin JM, Thymopentin therapy reduces the clinical severity of atopic dermatitis. J Allergy Clin Immunol, 85(5):927-33, 1990.   DOI
28 Helena Aniansson Zdolsek, Jan Ernerudh, Patrick G. Holt, Joacim Nilsson, Bengt Bjorksten, Expression of the T-Cell Markers CD3, CD4 and CD8 in Healthy and Atopic Children during the First 18 Months of Life. Arch Allergy Immunol, 119:6-12, 1999.   DOI
29 Everett H. Meyer, Rosemarie H. DeKruyff, and Dale T. Umetsu, T Cells and NKT Cells in the Pathogenesis of Asthma, Annual Review of Medicine, 59:281-292, 2007.
30 Maeda S, Yanagihara Y. Inflammatory cytokines (IL-4, IL-5 and IL-13). Nippon Rinsho, 59:1984-9, 2001.
31 Magnan AO, Mely LG, Camilla CA, Badier MM, Montero- Julian FA, Guillot CM, Casano BB, Prato SJ, Fert V, Bongrand P, Vervloet D: Assessment of the Th1/Th2 paradigm in whole blood in atopy and asthma. Increased IFN-gamma-producing CD8(+) T cells in asthma. Am J Respir Crit Care Med, 161;1790-1796, 2000.   DOI
32 Vanhecke D, Leclercq G, Plum J and Vandekerckhove B, Characterization of distinct stages during the differentiation of human CD69+CD3+ thmocytes and identification of thymic emigrants. The Journal of Immunology, 155(4):1862-1872, 1995.
33 Rongcun Yang, Zhong Cai, Yuan Zhang, William H. Yutzy, IV, Katherine F. Roby and Richard B.S. Rodeen, CD80 in Immune Suppression by Mouse Ovarian Carcinoma-Associated Gr-1+CD11b+ Myeloid Cells. Cancer Research, 66:6807-6815, 2006.   DOI